Healthcare

WHO prequalifies new dengue vaccine; Read on to know all about TAK-003

WHO prequalifies new dengue vaccine; Read on to know all about TAK-003

GSK presents significantly positive outcomes of its vaccine against Shingles

KP2 variant, KP2 variant covid 19, JN.1 variant covid 19, covid cases, covid news, healthcare news,

FLiRT Variants in India: Can KP.2 lead to surge in COVID-19 cases this summer? Experts answer

CDSCO gives nod to Boehringer Ingelheim's therapy for rare and life-threatening skin disorder in India

CDSCO gives nod to Boehringer Ingelheim’s therapy for rare and life-threatening skin disorder in India

Cervical Cancer, Cervical cancer testing, cervical cancer diagnosis, cervical cancer kit, USFDA, Healthcare news, pharma news,

USFDA gives nod to Roche’s self-testing kit for cervical cancer in United States

FE Mental Health Series, Mental Health in India, Mental Health disorders, mental health illnesses in india, psychiatrists in india, healthcare news, mental health news,

FE Mental Health Series | India’s troubled minds! How land of 140 crore faces severe shortage of mental health experts

Eli Lilly CEO David Ricks says its obesity drug could enter India as early as 2025

Eli Lilly settles counterfeit versions of its popular diabetes drug

CDSCO forms committee to include new provisions for over-the-counter drugs

Biopharmaceutical M&A deals surge by 71 percent YoY during Q1 2024: GlobalData

Weight lost through Wegovy can be sustained for up to four years, claims Novo Nordisk

Health

When it comes to summer coolers, mixologists swear by homemade concoctions.

Stay cool, naturally

Numerous studies have established a link between long-term exposure to elevated noise levels and an increased risk of developing cardiovascular diseases.

Wake up to noise damage

animal protein, plant protein, proteins, health

Animal vs plant protein: What’s your ideal pick?

eyecare, summer, lifestyle, eyes, health

Eyecare in summer: How to protect eyes from the harsh sun

INTERVIEWS

Use of digital therapeutics for cardiac rehab has gained significant traction in India: Sidharth Srinivasan, CEO, Lupin Digital Health

Use of digital therapeutics for cardiac rehab has gained significant traction in India: Sidharth Srinivasan, CEO, Lupin Digital Health

We will continue to scale our clinic network and raise awareness among consumers: Amarinder Singh, Founder & CEO, Clove Dental

We will continue to scale our clinic network and raise awareness among consumers: Amarinder Singh, Founder & CEO, Clove Dental

Data analytics can play a crucial role in connecting the right patient with right drugs: Jaswinder Chadha, President & CEO, Axtria

Data analytics can play a crucial role in connecting the right patient with right drugs: Jaswinder Chadha, President & CEO, Axtria

In India, CGM usage trend has seen a gradual incline since its introduction in 2015: Dr. Subramaniam, Medical Affairs Head, Abbott Diabetes Care

In India, CGM usage trend has seen a gradual incline since its introduction in 2015: Dr. Subramaniam, Medical Affairs Head, Abbott Diabetes Care

Challenges in the diagnosis, treatment, and management of chronic diseases are plentiful in India: Prof. (Dr) D. Prabhakaran, Executive Director, CCDC

Challenges in the diagnosis, treatment, and management of chronic diseases are plentiful in India: Prof. (Dr) D. Prabhakaran, Executive Director, CCDC

Developments in CAR-T cell therapy and Nanotherapy exhibit promising potential: Dinesh Madhavan, President Group Oncology, Apollo Hospitals Enterprise Ltd. Recently, Apollo Cancer Centres has the AI-Precision Oncology Centre (AI-PoC) which can revolutionise cancer care in India. In an interview with Financial Express.com, Dinesh Madhavan, President, Group Oncology & International, Apollo Hospitals Enterprises Limited talked about the technological advancements in cancer treatment, role of AI-Precision Oncology Centre (AI-PoC), challenges among others. Excerpts: What is the status of Cancer in India? How Cancer Care and Treatment advanced in the country? The projected number of cancer cases in India is expected to rise to 15.7 lakh in 2025, reflecting a significant increase in cancer burden. The rise in cancer incidence underscores the urgent need for comprehensive approaches to prevention, early detection, and treatment. Despite the challenges, advancements in cancer care and treatment have been remarkable, with the establishment of state-of-the-art oncology centers equipped with cutting-edge technology. The development and implementation of advanced treatment modalities, such as precision medicine and targeted therapies, have been pivotal in improving patient outcomes. Collaboration between public and private healthcare sectors, as well as international partnerships, has played a crucial role in advancing cancer care in India. The rise in cancer burden necessitates strategic investments in research, development, and training programs to foster innovation and ensure the delivery of state-of-the-art cancer care across the country. India's focus on personalized and multidisciplinary approaches underscores its commitment to addressing the evolving needs of cancer patients and further advancing cancer care in the country. How technological advancements and improve cancer care and treatment in India? Key advancements centre on immune checkpoint inhibitors, heralding a transformative era in oncology through immunotherapy. This novel approach leverages the body's immune system to combat cancer cells. Moreover, developments in CAR T cell therapy and Nanotherapy exhibit promising potential, offering tailored treatments and potentially reshaping the landscape of cancer care. CAR T cell therapies in India, currently approved for B cell lymphomas, are set for rapid expansion within 12 to 16 months. Ongoing clinical trials in cities like Bangalore, Chennai, Kolkata, Mumbai and Delhi project a broader landscape. With India's vast population, a collaborative approach integrating private healthcare, government, and charities will likely introduce diverse CAR T therapy options. Anticipated CDSCO approvals will extend these therapies beyond B cell lymphomas, offering comprehensive treatments for diverse blood cancers nationwide. Advanced technologies such as AI-powered imaging and liquid biopsies have significantly enhanced early detection, improving the accuracy of diagnosing cancer at an early stage. Imaging technology developments have paved the way for more precise and effective treatment strategies, optimizing patient outcomes and minimizing the impact of treatment. We also have International collaborations that would serve as a catalyst for advancing oncology research and treatment in India by fostering knowledge exchange and technological advancements. Apollo's alliances, like the Oncology Alliance and Apollo Practicum, display the value of global participation, enabling Indian practitioners to interact with international experts and implement advanced treatments, such as Proton Beam Therapy, Bone Marrow Transplants, and Precision Oncology. These partnerships offer exposure to diverse medical experiences, technological innovations, and clinical trials, effectively closing the gap and enhancing India's expertise in combating cancer. What is AI-Precision Oncology Centre (AI-PoC)? What can be its role in the cancer landscape in India? The AI-Precision Oncology Centre (AI-PoC) at Apollo Cancer Centres is designed with a patient-centric approach, providing personalized identification of eligible patients for targeted therapy and immunotherapy as part of the diagnosis and treatment planning process. The groundbreaking Centre ensures accurate diagnosis, real-time insights, cancer risk assessment, treatment protocol, and a continuum of care. These advanced capabilities are instrumental in shaping the dynamics of cancer care in India. With the implementation of AI technology, Apollo Cancer Centres enhances the accuracy and effectiveness of cancer diagnosis and treatment, bridging essential policy and governance gaps within the Indian cancer scenario. It offers specialized medical services that facilitate accurate diagnosis, real-time insights, and tailored treatment protocols, significantly improving cancer care outcomes in India. Through its comprehensive and specialized approach, the AI-PoC plays a vital role in leveraging AI technology for precise cancer diagnosis, marking a significant advancement in the Indian cancer care landscape. It is dedicated to reshaping the horizons of oncology in India by opening up new and important opportunities through its advanced capabilities in cancer care. Harnessing artificial intelligence in Oncology facilitates the discovery of novel patient groups, aligning with India's objective to emerge as a global medical hub for affordable cancer care. By incorporating AI into cancer research and treatment, the AI-PoC aims to address major gaps in the cancer landscape in India, fostering improved patient outcomes and the overall progress of cancer care in the nation. What is the role of artificial intelligence in cancer care? What more needs to be done to improve the availability of these advancements? Artificial intelligence (AI) plays a crucial role in cancer care by enhancing early detection through analysis of patients' medical history and test results. For example, AI algorithms can analyze genetic data to identify mutations associated with increased cancer risk. AI also supports precision medicine by accurately identifying patients eligible for targeted therapy and immunotherapy, thereby, improving treatment outcomes and reducing unnecessary side effects. The application of AI in cancer care includes providing clinical decision support for cancer diagnosis and screening, thereby ensuring more accurate and timely diagnoses. Meanwhile, AI augments healthcare by assisting clinicians in decision-making, enhancing patient engagement, and optimizing treatment outcomes. AI-driven algorithms aid in patient reminders, drug dosages, surgical procedures, and follow-ups based on global data and experiences. To further improve the availability of these advancements, there is a need to invest in AI technology infrastructure and training for healthcare professionals. This will ensure widespread adoption and utilization of AI tools in different healthcare settings throughout India. Educating both healthcare professionals and the public about the benefits and limitations of AI in cancer care is vital to build trust and encourage widespread usage. This will help in overcoming any resistance to adopting AI tools and technologies. Continuous research and development in AI technologies tailored for cancer care are essential to ensure that the tools and applications remain relevant, effective, and adaptable to the evolving landscape of cancer treatment and research. What are some of the key challenges that cancer patients are facing in India? India grapples with substantial challenges in oncology research across cancer prevention, diagnosis, and treatment. The foremost hurdle lies in the widespread under insurance, where most individuals possess insufficient coverage for tertiary conditions. Additionally, the absence of a comprehensive national policy for preventable cancers like HPV vaccination hampers progress. The lack of a collaborative approach between government and private entities, and limited clinical trial emphasis further impede advancements in oncology, hindering optimal cancer prevention, early diagnosis, and effective treatments in the country. Infrastructure issues and the vast rural population pose challenges in accessing major cancer centers, leading to disparities in care and treatment outcomes. The push for "Make in India" fosters local production but must align with augmenting medical oncology and surgical oncology seats, diversifying programs, and establishing accessible neighborhood cancer centres. Without cancer being a notifiable disease, addressing these challenges remains arduous. Anything else that you would like to add? The AI-Precision Oncology Centre at Apollo Cancer Centres represents a significant leap in personalized oncology care, with India's first AI-driven Precision Oncology Centre (POC) launched in Bengaluru. With a strong commitment to personalized oncology care through AI, the centre marks a pivotal advancement, ensuring a brighter future for cancer patients and the overall landscape of oncology care in India. India's move towards becoming a global medical hub for affordable cancer care is further supported by the invaluable contributions of the AI-Precision Oncology Centre, ensuring new patient identification and improved care pathways in the fight against cancer. The investment in AI technology for precision oncology underscores Apollo Hospitals' commitment to leveraging advanced technologies for the benefit of patients, healthcare professionals, and the broader community, charting a new course in the fight against cancer.

Developments in CAR-T cell therapy and Nanotherapy exhibit promising potential: Dinesh Madhavan, President Group Oncology, Apollo Hospitals Enterprise Ltd.

Videos

Doctor Explains: Majority of cancer cases in India are diagnosed in stages 3 and 4

India’s TB Burden Explained: Awareness, timely diagnosis and proper treatment need of the hour

Doctor Explains: Menace of cancer in India

FE Healthcare Summit, FE Healthcare Summit 2022, Mansukh Mandaviya, Health news, healthcare news,

FE Healthcare Summit 2022: Affordable And Accessible Healthcare

DIAGNOSTIC

World Ovarian Cancer Day 2024,World Ovarian Cancer Day 2024 theme,World Ovarian Cancer Day theme,World Ovarian Cancer Day images,World Ovarian Cancer Day posters,World Ovarian Cancer Day slogans,Ovarian Cancer Day,Ovarian Cancer Day 2024

World Ovarian Cancer Day 2024: Can urine test detect the disease early?

Reliance-owned Strand Life Sciences develops prenatal genomic diagnostics portfolio

Reliance-owned Strand Life Sciences develops prenatal genomic diagnostics portfolio

aiims

Affordable, made-in-India cervical cancer tests to be available soon—Check details

Roche Diagnostics India launches heart failure test for diabetics in India

Roche Diagnostics India launches heart failure test for diabetics in India

More Diagnostic

PHARMA NEWS

French drugmaker Sanofi to invest over €1 billion in production sites

French drugmaker Sanofi to invest over €1 billion in production sites

Merck halts skin cancer combination therapy testing in late-stage study

Merck halts skin cancer combination therapy testing in late-stage study

Strides Pharma gets USFDA nod for its drug to treat elevated phosphorous levels

Strides Pharma gets USFDA nod for its drug to treat elevated phosphorous levels

Alembic Pharmaceuticals gets 5 USFDA product approvals in Q1FY25

Alembic Pharmaceuticals gets 5 USFDA product approvals in Q1FY25

Biocon, Canada market, biosimilars company, YESAFILI®, prefilled syringes, patent litigation

Biocon signs deal with Medix for distribution and commercialisation of weight loss drug in Mexico

Covishield

Serum Institute says it stopped manufacturing and supply of extra Covishield doses since December 2021

More Pharma News

WELLNESS

alcohol beverages industry,

Trying to lose weight? Keep the liquid calories in check

back pain, chronic pain, healthcare, wellness

Cold & chronic pain

new year 2024, new years day, December 31, December 31 celebrations, wellbeing, resolutions for 2024

New Year’s resolutions, and how to keep them

Nutrition, Access to nutrition, healthy food, healthy eating habits, healthcare news, wellness news,

Multi-sectoral response is required to improve access to nutrition: Greg S Garrett, Executive Director, ATNI

Market Data